Cardiac disease in pregnancy and hypertension: Difference between revisions
m (Bot: Removing from Primary care) |
|||
| (3 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Cardiac disease in pregnancy}} | {{Cardiac disease in pregnancy}} | ||
| Line 5: | Line 6: | ||
==Overview== | ==Overview== | ||
Hypertension in pregnancy can be broadly classified as chronic hypertension, [[pregnancy-induced hypertension]] (or [[gestational hypertension]]), and [[pre-eclampsia]] / [[eclampsia]]. All of these conditions are the source of significant maternal morbidity and mortality. | Hypertension in pregnancy can be broadly classified as chronic hypertension, [[pregnancy-induced hypertension]] (or [[gestational hypertension]]), and [[pre-eclampsia]] / [[eclampsia]]. All of these conditions are the source of significant maternal morbidity and mortality. | ||
==Hypertension== | |||
==Chronic Hypertension in Pregnancy== | ===Chronic Hypertension in Pregnancy=== | ||
This condition is defined as [[hypertension]] (blood pressure ≥140 mm Hg systolic or ≥90 mm Hg diastolic) present before pregnancy or that is diagnosed before the 20th week of gestation. In general, antihypertensive medications are effective in treating this condition, in contrast to pre-eclampsia.<ref name="pmid10920346">{{cite journal| author=| title=Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. | journal=Am J Obstet Gynecol | year= 2000 | volume= 183 | issue= 1 | pages= S1-S22 | pmid=10920346 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10920346 }} </ref> | This condition is defined as [[hypertension]] (blood pressure ≥140 mm Hg systolic or ≥90 mm Hg diastolic) present before pregnancy or that is diagnosed before the 20th week of gestation. In general, antihypertensive medications are effective in treating this condition, in contrast to pre-eclampsia.<ref name="pmid10920346">{{cite journal| author=| title=Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. | journal=Am J Obstet Gynecol | year= 2000 | volume= 183 | issue= 1 | pages= S1-S22 | pmid=10920346 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10920346 }} </ref> | ||
Safe anti-hypertensive drugs that can be used during pregnancy include; | Safe anti-hypertensive drugs that can be used during pregnancy include; | ||
===First Choice=== | ====First Choice==== | ||
*[[Methyldopa]], but it is often not available. | *[[Methyldopa]], but it is often not available. | ||
===Second Choice=== | ====Second Choice==== | ||
*Long-acting [[nifedipine]] | *Long-acting [[nifedipine]] | ||
===Third Choice=== | ====Third Choice==== | ||
*[[Labetalol]] | *[[Labetalol]] | ||
=== | ====Contraindication==== | ||
*[[ACE inhibition]] can be teratogenic | *[[ACE inhibition]] can be teratogenic | ||
*[[ARBS]]s can be teratogenic | *[[ARBS]]s can be teratogenic | ||
| Line 28: | Line 29: | ||
'''''For a more broad discussion of chronic hypertension, click [[hypertension|here]].''''' | '''''For a more broad discussion of chronic hypertension, click [[hypertension|here]].''''' | ||
==Pregnancy Induced Hypertension== | ===Pregnancy Induced Hypertension=== | ||
[[Pregnancy-induced hypertension]] ([[PIH]]) (or gestational hypertension) is defined as the development of new arterial hypertension in a pregnant woman after 20 weeks gestation. There is no specific treatment, but is monitored closely to rapidly identify [[pre-eclampsia]] and its life-threatening complications ([[HELLP syndrome]] and [[eclampsia]]). Treatment options are limited, as many antihypertensives may negatively affect the fetus; [[methyldopa]] and [[labetalol]] are most commonly administered to treat severe pregnancy hypertension. | [[Pregnancy-induced hypertension]] ([[PIH]]) (or gestational hypertension) is defined as the development of new arterial hypertension in a pregnant woman after 20 weeks gestation. There is no specific treatment, but is monitored closely to rapidly identify [[pre-eclampsia]] and its life-threatening complications ([[HELLP syndrome]] and [[eclampsia]]). Treatment options are limited, as many antihypertensives may negatively affect the fetus; [[methyldopa]] and [[labetalol]] are most commonly administered to treat severe pregnancy hypertension. | ||
| Line 34: | Line 35: | ||
'''''For a more broad discussion of pregnancy induced hypertension, click [[Pregnancy-induced hypertension|here]].''''' | '''''For a more broad discussion of pregnancy induced hypertension, click [[Pregnancy-induced hypertension|here]].''''' | ||
==Pre-eclampsia== | ===Pre-eclampsia=== | ||
Pre-eclampsia (US: preeclampsia) is a [[medical condition]] where [[hypertension]] arises in pregnancy ([[pregnancy-induced hypertension]]) in association with significant protein in the urine. Its cause remains unclear, although the principal cause appears to be a substance or substances from the [[placenta]] causing [[endothelial dysfunction]] in the maternal blood vessels.<ref name=DrifeMagowan>Drife JO, Magowan (eds). ''Clinical Obstetrics and Gynaecology'', chapter 39, pp 367-370. ISBN 0-7020-1775-2.</ref> While [[blood pressure]] elevation is the most visible sign of the disease, it involves generalized damage to the maternal endothelium and kidneys and liver, with the release of vasopressive factors only secondary to the original damage. | Pre-eclampsia (US: preeclampsia) is a [[medical condition]] where [[hypertension]] arises in pregnancy ([[pregnancy-induced hypertension]]) in association with significant protein in the urine. Its cause remains unclear, although the principal cause appears to be a substance or substances from the [[placenta]] causing [[endothelial dysfunction]] in the maternal blood vessels.<ref name=DrifeMagowan>Drife JO, Magowan (eds). ''Clinical Obstetrics and Gynaecology'', chapter 39, pp 367-370. ISBN 0-7020-1775-2.</ref> While [[blood pressure]] elevation is the most visible sign of the disease, it involves generalized damage to the maternal endothelium and kidneys and liver, with the release of vasopressive factors only secondary to the original damage. | ||
| Line 42: | Line 43: | ||
'''''For a more detailed discussion of pre-eclampsia, click [[Pre-eclampsia|here]].''''' | '''''For a more detailed discussion of pre-eclampsia, click [[Pre-eclampsia|here]].''''' | ||
==Eclampsia== | ===Eclampsia=== | ||
Eclampsia, an acute and life-threatening complication of [[pregnancy]], is characterized by the appearance of [[tonic-clonic seizure]]s in a patient who had developed [[preeclampsia]]; rarely does eclampsia occur without preceding preeclamptic symptoms. ''Hypertensive disorder of pregnancy'' and ''toxemia of pregnancy'' are terms used to encompass both preeclampsia and eclampsia. Seizures and coma that happen during pregnancy but are due to preexisting or organic brain disorders are not eclampsia. | Eclampsia, an acute and life-threatening complication of [[pregnancy]], is characterized by the appearance of [[tonic-clonic seizure]]s in a patient who had developed [[preeclampsia]]; rarely does eclampsia occur without preceding preeclamptic symptoms. ''Hypertensive disorder of pregnancy'' and ''toxemia of pregnancy'' are terms used to encompass both preeclampsia and eclampsia. Seizures and coma that happen during pregnancy but are due to preexisting or organic brain disorders are not eclampsia. | ||
| Line 57: | Line 58: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[CME Category::Cardiology]] | |||
[[Category:Disease]] | |||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Emergency medicine]] | |||
[[Category:Obstetrics]] | [[Category:Obstetrics]] | ||
Latest revision as of 20:48, 29 July 2020
|
Cardiac disease in pregnancy Microchapters |
|
Diagnosis |
|---|
|
Catheterization: |
|
Treatment |
|
Special Scenarios:
|
|
Cardiac disease in pregnancy and hypertension On the Web |
|
American Roentgen Ray Society Images of Cardiac disease in pregnancy and hypertension |
|
Directions to Hospitals Treating Cardiac disease in pregnancy |
|
Risk calculators and risk factors for Cardiac disease in pregnancy and hypertension |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Anjan K. Chakrabarti, M.D. [2]; Stacie Zelman, M.D. [3]
Overview
Hypertension in pregnancy can be broadly classified as chronic hypertension, pregnancy-induced hypertension (or gestational hypertension), and pre-eclampsia / eclampsia. All of these conditions are the source of significant maternal morbidity and mortality.
Hypertension
Chronic Hypertension in Pregnancy
This condition is defined as hypertension (blood pressure ≥140 mm Hg systolic or ≥90 mm Hg diastolic) present before pregnancy or that is diagnosed before the 20th week of gestation. In general, antihypertensive medications are effective in treating this condition, in contrast to pre-eclampsia.[1]
Safe anti-hypertensive drugs that can be used during pregnancy include;
First Choice
- Methyldopa, but it is often not available.
Second Choice
- Long-acting nifedipine
Third Choice
Contraindication
- ACE inhibition can be teratogenic
- ARBSs can be teratogenic
- Atenolol can cause fetal growth retardation
- Diuretics can reduce placental perfusion
For a more broad discussion of chronic hypertension, click here.
Pregnancy Induced Hypertension
Pregnancy-induced hypertension (PIH) (or gestational hypertension) is defined as the development of new arterial hypertension in a pregnant woman after 20 weeks gestation. There is no specific treatment, but is monitored closely to rapidly identify pre-eclampsia and its life-threatening complications (HELLP syndrome and eclampsia). Treatment options are limited, as many antihypertensives may negatively affect the fetus; methyldopa and labetalol are most commonly administered to treat severe pregnancy hypertension.
For a more broad discussion of pregnancy induced hypertension, click here.
Pre-eclampsia
Pre-eclampsia (US: preeclampsia) is a medical condition where hypertension arises in pregnancy (pregnancy-induced hypertension) in association with significant protein in the urine. Its cause remains unclear, although the principal cause appears to be a substance or substances from the placenta causing endothelial dysfunction in the maternal blood vessels.[2] While blood pressure elevation is the most visible sign of the disease, it involves generalized damage to the maternal endothelium and kidneys and liver, with the release of vasopressive factors only secondary to the original damage.
Pre-eclampsia may develop at varying times within pregnancy and its progress differs among patients; most cases are diagnosed pre-term. It has no known cure apart from ending the pregnancy (induction of labor or abortion). It may also occur up to six weeks post-partum. Of dangerous pregnancy complications, it is the most common; it may affect both the mother and the fetus.[2]
For a more detailed discussion of pre-eclampsia, click here.
Eclampsia
Eclampsia, an acute and life-threatening complication of pregnancy, is characterized by the appearance of tonic-clonic seizures in a patient who had developed preeclampsia; rarely does eclampsia occur without preceding preeclamptic symptoms. Hypertensive disorder of pregnancy and toxemia of pregnancy are terms used to encompass both preeclampsia and eclampsia. Seizures and coma that happen during pregnancy but are due to preexisting or organic brain disorders are not eclampsia.
The term is derived from the Greek and refers to a flash, a term used by Hippocrates to designate a fever of sudden onset. [3]
Typically patients show signs of pregnancy-induced hypertension and proteinuria prior to the onset of the hallmark of eclampsia, the eclamptic convulsion. Other cerebral signs may precede the convulsion such as nausea, vomiting, headaches, and cortical blindness. In addition, with the advancement of the pathophysiological process, other organ symptoms may be present including abdominal pain, liver failure, signs of the HELLP syndrome, pulmonary edema, and oliguria. The fetus may have been already compromised by intrauterine growth retardation, and with the toxemic changes during eclampsia may suffer fetal distress. Placental bleeding and placental abruption may occur.
The treatment of eclampsia requires prompt intervention and aims to prevent further convulsions, control the elevated blood pressure and deliver the fetus.
For a more detailed discussion of eclampsia, click here.
References
- ↑ "Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy". Am J Obstet Gynecol. 183 (1): S1–S22. 2000. PMID 10920346.
- ↑ 2.0 2.1 Drife JO, Magowan (eds). Clinical Obstetrics and Gynaecology, chapter 39, pp 367-370. ISBN 0-7020-1775-2.
- ↑ Chesley LC. Hypertensive Disorders in Pregnancy, in Williams Obstetrics, 14th Edition. Appleton Century Crofts, New York (1971), page 700.